Labiotech.eu

Expert Advice 27 Sep 2018

How to Build an Outstanding Personal Brand in the Biopharma Industry

“Your brand is what people say about you when you’re not in the room.” – Jeff Bezos Your personal brand is essentially your professional reputation, publicised. In this crazy century, every individual has become the writer, editor, and creative director of their own publication. The internet has made the wisdom of company branding […]

September 27, 2018 - 9 minutesmins - By James Mathison

News and Trends 26 Sep 2018

Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline

Rare genetic diseases in the central nervous system may be less of a headache in future, as Barcelona-based biotech Minoryx has raised €21.3M in series B fundraising to test its lead drug candidate against other rare neurological conditions. According to Philippe Monteyne, partner at investor Fund+, “it is the largest investment in biotech in Spain […]

September 26, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 26 Sep 2018

Fish Oils Finally Reel in Positive Results for Cardiovascular Disease

Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III trial results. The treatment, called Vascepa, significantly reduced the risk of strokes, heart attacks, and death. It also had a good safety profile in the over 8,000 enrolled patients, who were already taking statins. These […]

September 26, 2018 - 2 minutesmins - By Jonathan Smith

aktiia blood pressure people crossing v2

More News! 25 Sep 2018

24-Hour Blood Pressure Bracelet Could Combat Hypertension

For those with blood pressure problems who hate blood pressure cuffs, hope is here. Swiss biotech aktiia has raised €3.6M to market a medical bracelet that could monitor your blood pressure 24/7. “Think of aktiia as the first medical device to measure blood pressure for long periods of time … that does not influence your […]

September 25, 2018 - 2 minutesmins - By Jonathan Smith

Interview 25 Sep 2018

How to Overcome Failure as a Biotech Company

Turning failure into success is a difficult but much needed skill in a high-risk industry such as biotech. At our latest Labiotech Refresh event, Christine Placet, now the CEO of ophthalmic gene therapy company Horama, shared her personal story of how she saved her previous company, Trophos, from an almost certain failure. The mission of […]

September 25, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Sep 2018

Gene Therapy Improves Eyesight of Patients With Inherited Blindness

UK startup Nightstar Therapeutics has reported good safety and early signs of visual improvements in a Phase I/II trial with a gene therapy for a rare form of inherited blindness. One month after being treated with Nightstar’s gene therapy, five of the 18 patients enrolled in the trial have already shown improvements in their vision. […]

September 24, 2018 - 2 minutesmins - By Jonathan Smith

Alanna Lynch bioart gut feelings microbiome

News and Trends 22 Sep 2018

Art Made With Kombucha Explores the Science of the Microbiome

Artist Alanna Lynch uses kombucha as an art medium to explore our relationship with the microbiome, which is now in the spotlight of human health. An ancient drink made of fermented tea, kombucha is now, over 2,000 years later, exploding in popularity. This week, Coca-Cola acquired an Australian kombucha company in an aim to enter […]

September 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Sep 2018

RNA Therapy Shows Promise for Treating Liver Cancer

British biotech MiNA Therapeutics’ innovative RNA treatment may enhance liver cancer patients’ response to standard cancer therapies, suggest early results from a Phase I/IIa clinical trial. When they received the biotech’s small activating RNA (saRNA) treatment, two patients showed complete responses after being given the cancer treatment sorafenib and one showed a partial response to […]

September 20, 2018 - 2 minutesmins - By Jonathan Smith

More News! 19 Sep 2018

Argenx Attracts Huge €250M Investment Following Positive Phase II Trial

Belgian biotech Argenx raised over €250M in public investment on the Nasdaq Stock Market after announcing positive Phase II results for its lead autoimmune drug candidate. The company now plans to progress efgartigimod, an antibody fragment inspired by llama antibodies, to Phase III trials for treatment of the autoimmune blood disease primary immune thrombocytopenia (ITP). […]

September 19, 2018 - 2 minutesmins - By Jonathan Smith

More News! 19 Sep 2018

This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity Testing

Poietis has partnered with the pharma company Servier to develop a 4D bioprinted liver model that could predict liver toxicity of drugs better than current methods. Liver toxicity testing is one of the key tests that are performed during preclinical trials with investigational drugs. “The role of the liver is to degrade substances toxic to […]

September 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 19 Sep 2018

Using Stem Cells to Save the Northern White Rhino

Stem cells are recognized for their therapeutic promise in regenerative medicine, but did you know that they’re also being used to save endangered species? Four hours north of Nairobi, closely safeguarded by armed security, the last remaining northern white rhinoceros are waiting for extinction. Only two animals are left, both of them living in a […]

September 19, 2018 - 7 minutesmins - By External Contributor

News and Trends 18 Sep 2018

Cockle Molecules Could Help Fight Cancer

As you eat your plate of delicious cockles, spare a thought for how their sugars might help to tackle cancer, suggest researchers from the University of Salford, UK. Testing cockle-derived sugars on cancer cells in the lab, the research group found that they have a similar anti-cancer effect to many regular chemotherapy drugs, but with […]

September 18, 2018 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How to Build an Outstanding Personal Brand in the Biopharma Industry

Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline

Fish Oils Finally Reel in Positive Results for Cardiovascular Disease

24-Hour Blood Pressure Bracelet Could Combat Hypertension

How to Overcome Failure as a Biotech Company

Gene Therapy Improves Eyesight of Patients With Inherited Blindness

Art Made With Kombucha Explores the Science of the Microbiome

RNA Therapy Shows Promise for Treating Liver Cancer

Argenx Attracts Huge €250M Investment Following Positive Phase II Trial

This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity Testing

Using Stem Cells to Save the Northern White Rhino

Cockle Molecules Could Help Fight Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!